ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.522,92
-0,42%
S&P 500
5.648,77
0,31%
Dow Jones
40.759,22
1,36%
Euro vs US Dollar
1,08808
-0,17%
Bitcoin
64.430,18
-0,66%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) News

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPRX
DatumZeitQuelleÜberschriftSymbolFirma
21/03/201421h15Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h59Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h58Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h54Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h54Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h53Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h52Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h52Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h52Edgar (US Regulatory)Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h52Edgar (US Regulatory)Registration of Securities by Certain Investment Companies. Declaration of Election Rule 24f-2 Notice (24f-2nt)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h51Edgar (US Regulatory)Registration of Securities by Certain Investment Companies. Declaration of Election Rule 24f-2 Notice (24f-2nt)NASDAQ:OPRXOptimizeRx Corporation
21/03/201415h51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPRXOptimizeRx Corporation
20/03/201419h44MarketwiredOPTIMIZERx Announces Sponsorship of the CBInet eRx and EHR ConferenceNASDAQ:OPRXOptimizeRx Corporation
20/03/201415h24Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:OPRXOptimizeRx Corporation
20/03/201415h23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OPRXOptimizeRx Corporation
19/03/201422h18Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:OPRXOptimizeRx Corporation
19/03/201422h18Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)NASDAQ:OPRXOptimizeRx Corporation
19/03/201422h17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OPRXOptimizeRx Corporation
19/03/201421h13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPRXOptimizeRx Corporation
18/03/201416h55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
18/03/201414h31MarketwiredOptimizeRx Completes Capital Raise to Exercise Securities Redemption Option Agreement With VicisNASDAQ:OPRXOptimizeRx Corporation
14/03/201411h02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:OPRXOptimizeRx Corporation
11/02/201420h58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
05/02/201417h06MarketwiredOPTIMIZERx Announces Accounting ChangeNASDAQ:OPRXOptimizeRx Corporation
22/01/201413h30MarketwiredOPTIMIZERx Announces Record Preliminary 2013 4th Quarter Results and UpdateNASDAQ:OPRXOptimizeRx Corporation
16/01/201417h30MarketwiredOPTIMIZERx Corporation to Present at Noble Financial Capital Markets' Tenth Annual Equity ConferenceNASDAQ:OPRXOptimizeRx Corporation
07/01/201415h34MarketwiredGrey Healthcare Group & OptimizeRx Announce Partnership to Expand Offerings Through EHRsNASDAQ:OPRXOptimizeRx Corporation
03/01/201416h09MarketwiredOPTIMIZERx Corporation Executes New Terms to Securities Redemption Option Agreement With VicisNASDAQ:OPRXOptimizeRx Corporation
14/11/201317h07MarketwiredOPTIMIZERx Corporation Q-3 Earnings CallNASDAQ:OPRXOptimizeRx Corporation
08/10/201318h26MarketwiredOPTIMIZERx Announces Record Preliminary 2013 Third Quarter Results and UpdateNASDAQ:OPRXOptimizeRx Corporation
 Showing the most relevant articles for your search:NASDAQ:OPRX

Kürzlich von Ihnen besucht

NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
DBI
TDXP
Tec DAX
CCOM
US500
US 500
TG
RHM
Rheinmetall
TG
BAYN
Bayer
TG
LHA
Deutsche Lufthansa
USOTC
BNPQY
BNP Paribas (QX)
TG
432
Arbor Metals
TG
DBK
Deutsche Bank
TG
MBG
MercedesBenz
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten